JP2024539641A5 - - Google Patents
Info
- Publication number
- JP2024539641A5 JP2024539641A5 JP2024522321A JP2024522321A JP2024539641A5 JP 2024539641 A5 JP2024539641 A5 JP 2024539641A5 JP 2024522321 A JP2024522321 A JP 2024522321A JP 2024522321 A JP2024522321 A JP 2024522321A JP 2024539641 A5 JP2024539641 A5 JP 2024539641A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- substantially described
- novel products
- manufacturing methods
- manufacturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256037P | 2021-10-15 | 2021-10-15 | |
| US63/256,037 | 2021-10-15 | ||
| US202263358897P | 2022-07-07 | 2022-07-07 | |
| US63/358,897 | 2022-07-07 | ||
| PCT/US2022/078023 WO2023064843A1 (en) | 2021-10-15 | 2022-10-13 | Inhibitors of mutant ret kinases for use in treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539641A JP2024539641A (ja) | 2024-10-29 |
| JP2024539641A5 true JP2024539641A5 (https=) | 2025-10-22 |
Family
ID=84238097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522321A Pending JP2024539641A (ja) | 2021-10-15 | 2022-10-13 | 癌の治療に使用するための変異ｒｅｔキナーゼの阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250064809A1 (https=) |
| EP (1) | EP4415718A1 (https=) |
| JP (1) | JP2024539641A (https=) |
| WO (1) | WO2023064843A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0915231A2 (pt) * | 2008-07-08 | 2018-06-12 | Intellikine Inc | compostos inibidores de quinase e métodos de uso |
| WO2017178844A1 (en) | 2016-04-15 | 2017-10-19 | Cancer Research Technology Limited | Heterocyclic compounds as ret kinase inhibitors |
| GB201705971D0 (en) * | 2017-04-13 | 2017-05-31 | Cancer Res Tech Ltd | Inhibitor compounds |
| EP3740490A1 (en) * | 2018-01-18 | 2020-11-25 | Array Biopharma, Inc. | Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors |
| JP7060694B2 (ja) * | 2018-01-18 | 2022-04-26 | アレイ バイオファーマ インコーポレイテッド | Ｒｅｔキナーゼ阻害剤としての置換ピロロ［２，３－ｄ］ピリミジン化合物 |
-
2022
- 2022-10-13 EP EP22802439.4A patent/EP4415718A1/en active Pending
- 2022-10-13 JP JP2024522321A patent/JP2024539641A/ja active Pending
- 2022-10-13 WO PCT/US2022/078023 patent/WO2023064843A1/en not_active Ceased
-
2024
- 2024-04-04 US US18/626,722 patent/US20250064809A1/en active Pending